Cervical cancer usually develops gradually through precancerous changes. Screening can detect these changes before invasive cancer develops, and HPV vaccination can reduce the risk of HPV infection and HPV-related cancers.
Bleeding after sex
Cervical cancer is cancer that develops in the cervix, the lower part of the uterus that connects to the vagina. Persistent infection with high-risk human papillomavirus (HPV) causes almost all cervical cancers.
Female reproductive anatomy showing uterus, cervix, vagina, ovaries and nearby pelvic structures.
Cervical cancer usually develops gradually through precancerous changes. Screening can detect these changes before invasive cancer develops, and HPV vaccination can reduce the risk of HPV infection and HPV-related cancers.
Female reproductive anatomy showing uterus, cervix, vagina, ovaries and nearby pelvic structures.
The cervix is the lower portion of the uterus and forms the passage between the uterus and vagina.
Most cervical cancers are associated with persistent infection by high-risk HPV types. Persistent infection can produce precancerous cellular changes that may eventually become invasive cancer.
Persistent high-risk HPV infection can cause cellular changes in the cervix. Some precancerous changes progress over time to invasive cancer if they are not detected and treated.
Visual comparison of squamous cell carcinoma and adenocarcinoma of the cervix.
Classification depends on histology, tumor extent, lymph-node involvement and distant spread. Staging is used to guide treatment.
The major cervical cancer types include squamous cell carcinoma and adenocarcinoma. Less common histologic types also occur.
Visual showing abnormal vaginal bleeding, discharge, pelvic pain and pain during sex.
Bleeding after sex
Bleeding after menopause
Bleeding between periods
Heavier or longer periods
Watery or blood-stained vaginal discharge
Pelvic pain
Pain during sex
Advanced urinary, bowel, back or leg symptoms
HPV infection pathway showing persistent high-risk HPV → precancerous cervical changes → possible invasive cancer.
Persistent infection with high-risk HPV is the main cause. Factors that increase the chance of persistent HPV infection or cervical cancer include immune suppression and tobacco smoking.
Persistent high-risk HPV infection
Smoking
Immune suppression
Inadequate screening
Other factors associated with persistent HPV infection
Screening result → clinical evaluation → colposcopy → biopsy → pathology → staging.
Evaluation may include medical and family history, physical and pelvic examination, colposcopy and biopsy. Imaging may be used to determine disease extent after diagnosis.
Abnormal vaginal bleeding
Persistent unusual vaginal discharge
Pelvic pain
Abnormal cervical screening result
HPV testing
Cervical cytology where used
Blood tests when clinically indicated
MRI
CT
PET-CT
Other imaging based on suspected spread
Pelvic examination
Colposcopy
Cervical biopsy
Endocervical curettage
LEEP
Cone biopsy
Cervical infection
Cervical polyps
Fibroids
Hormonal causes of abnormal bleeding
Other gynecologic conditions
Illustration showing cervical cancer progression from disease confined to cervix through local/regional and distant spread.
Cervical cancer is staged according to the extent of disease. Stage I is limited to the cervix; later stages reflect increasing local, regional or distant involvement.
Staging or grading systems differ between diseases. The information here is educational and should be interpreted by a qualified healthcare professional in the context of the individual case.
Treatment pathway showing surgery, radiation, chemotherapy and systemic treatment according to stage.
Treatment depends on stage, tumor characteristics, overall health and fertility considerations. Options may include surgery, radiation therapy, chemotherapy, targeted therapy and other systemic treatments.
Chemotherapy may be used according to stage and treatment plan.
Targeted therapy may be used in selected advanced disease.
Immunotherapy may be used in selected patients depending on disease characteristics.
Supportive medicines may be used for treatment-related symptoms.
Medicines listed here are for educational information only. Do not start, stop, or change a medicine without professional medical advice.
Possible complications include bleeding, urinary or bowel problems, pelvic pain, leg swelling, fistulas, obstruction and complications from surgery, chemotherapy or radiation.
Heavy vaginal bleeding with dizziness or fainting
Severe pelvic or abdominal pain
Severe weakness or collapse
Difficulty urinating with severe pain or swelling
If symptoms are severe, rapidly worsening, or life-threatening, seek emergency medical care immediately.
Factors affecting outlook: stage, lymph nodes, tumor characteristics, response and overall health.
Prognosis depends strongly on stage, lymph-node involvement, tumor characteristics, treatment response and overall health. Early detection generally provides more treatment options.
Survival statistics describe outcomes in groups of people and cannot predict exactly what will happen to one individual. Prognosis depends on factors such as cancer stage, tumor biology, treatment response, overall health, and follow-up.
Cervical cancer remains a major public-health problem. IARC GLOBOCAN 2022 estimated 127,526 new cervical cancer cases among women in India.
HPV vaccination, appropriate cervical screening and treatment of precancerous lesions are major prevention strategies. Avoiding tobacco can also reduce risk.
What did my HPV or cervical screening result show?
Do I need colposcopy or biopsy?
What is the cancer stage?
Could treatment affect fertility?
What follow-up schedule will I need?
BimariDur provides educational health information to help people understand diseases, symptoms, tests, and treatment concepts. It does not replace examination, diagnosis, or treatment by a qualified healthcare professional.
Do not delay professional medical care because of information read on BimariDur.